Format

Send to

Choose Destination
Int J Gynaecol Obstet. 2010 Mar;108(3):228-32. doi: 10.1016/j.ijgo.2009.09.027. Epub 2009 Nov 27.

Home administration of misoprostol for early medical abortion in India.

Author information

1
Gynuity Health Projects, New York, NY 10010, USA. hbracken@gynuity.org

Abstract

OBJECTIVE:

To assess the efficacy and acceptability of home administration of misoprostol for early medical abortion in Indian family planning clinics.

METHODS:

In this prospective cohort study, consenting pregnant women (n=599) with amenorrhea of 8 weeks or less seeking termination of pregnancy received 200mg of oral mifepristone followed 48 hours later with 400microg of oral misoprostol, administered either at home or at the clinic.

RESULTS:

Almost all women (88.4%) chose to take misoprostol home. There was no statistical difference in success rates between home and clinic users (89.0% vs 92.4%, Pearson chi(2)=0.7; P=0.395). Most women in both the home (90.7%) and clinic (92.3%) groups were satisfied or very satisfied with the procedure.

CONCLUSION:

Home administration of misoprostol is safe and feasible for introduction into medical abortion services in India.

PMID:
19945104
DOI:
10.1016/j.ijgo.2009.09.027
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center